Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1RJB

Crystal Structure of FLT3

Summary for 1RJB
Entry DOI10.2210/pdb1rjb/pdb
DescriptorFL cytokine receptor (2 entities in total)
Functional Keywordskinase, autoinhibition, juxtamembrane domain, transferase
Biological sourceHomo sapiens (human)
Cellular locationMembrane; Single-pass type I membrane protein: P36888
Total number of polymer chains1
Total formula weight39799.32
Authors
Griffith, J.,Black, J.,Faerman, C.,Swenson, L.,Wynn, M.,Lu, F.,Lippke, J.,Saxena, K. (deposition date: 2003-11-19, release date: 2004-02-03, Last modification date: 2024-02-14)
Primary citationGriffith, J.,Black, J.,Faerman, C.,Swenson, L.,Wynn, M.,Lu, F.,Lippke, J.,Saxena, K.
The structural basis for autoinhibition of FLT3 by the juxtamembrane domain.
Mol.Cell, 13:169-178, 2004
Cited by
PubMed Abstract: FLT3 is a type III receptor tyrosine kinase that is thought to play a key role in hematopoiesis. Certain classes of FLT3 mutations cause constitutively activated forms of the receptor that are found in significant numbers of patients with acute myelogenous leukemia (AML). The mutations occur either in the activation loop, for example, as point mutations of Asp835 or as internal tandem duplication (ITD) sequences in the juxtamembrane (JM) domain. To further understand the nature of FLT3 autoinhibition and regulation, we have determined the crystal structure of the autoinhibited form of FLT3. This structure shows the autoinhibitory conformation of a complete JM domain in this class of receptor tyrosine kinases. The detailed inhibitory mechanism of the JM domain is revealed, which is likely utilized by other members of type III receptor tyrosine kinases.
PubMed: 14759363
DOI: 10.1016/S1097-2765(03)00505-7
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

246031

数据于2025-12-10公开中

PDB statisticsPDBj update infoContact PDBjnumon